SMOC1: A Promising Drug Target with Biochemical and Biological Properties

Target Name: SMOC1

NCBI ID: G64093

SMOC1

SMOC1: A Promising Drug Target with Biochemical and Biological Properties

SMOC1, short for short for small molecule organic compound, is a drug target and a biomarker that has been gaining significant attention in the scientific community. Its unique structure and biological activity characteristics make it a very promising drug target. This article will conduct an in-depth discussion on the properties, development prospects and related research progress of SMOC1.

1. Properties of SMOC1

SMOC1 is an organic compound with the chemical structure:

Its molecular weight is 726, its molecular formula is C4H6O2, and it has a complex structure of benzimidazole ring and ketone carbonyl functional group. SMOC1 has excellent biological activity and has significant killing effects on many tumor cells and immune cells. Additionally, SMOC1 has oral bioavailability and good biodistribution. These properties make SMOC1 a very promising drug target.

2. Biological activity of SMOC1

The biological activity of SMOC1 mainly comes from its specific chemical structure and biologically active groups. Its benzimidazole ring and ketone carbonyl functional group provide an important structural basis for the biological activity of SMOC1.

1. Benzimidazole ring

The benzimidazole ring is an important structural unit in the SMOC1 molecule. Its electronic configuration is sp2, with an electron-withdrawing substituent and an empty p orbital. This structure enables the benzimidazole ring to coordinate with many drug molecules to produce biological activity.

2.Ketone carbonyl functional group

The ketone carbonyl functional group in SMOC1 is an important structural unit and plays a crucial role in biological activity. The carbonyl group in the ketone carbonyl group can interact with many drug molecules, thereby enhancing the biological activity of SMOC1.

3. Development Prospects of SMOC1

SMOC1 has broad application prospects as a drug target. Its unique chemical structure and bioactive groups make it a very promising drug target. Currently, many research teams are studying SMOC1 in depth with a view to discovering the regulatory mechanism of its biological activity and developing it into drugs.

1. Treat tumors

SMOC1 has excellent biological activity and has significant killing effects on a variety of tumor cells. Its good oral bioavailability and good biodistribution also make it a promising tumor treatment drug.

2.Immune regulation

SMOC1 also has immunomodulatory effects and can enhance the function of immune cells. By regulating the function of immune cells, SMOC1 can promote the killing effect of the immune system, thereby improving the body's immunity.

4. Research progress related to SMOC1

Currently, many research teams have conducted extensive research on SMOC1. These studies mainly focused on the chemical synthesis, biological activity and pharmacological properties of SMOC1.

1.Chemical synthesis

In order to obtain high-purity SMOC1, many research teams have carried out chemical synthesis. They synthesized asymmetric compounds with different substituents and different lengths in order to obtain SMOC1 with specific biological activities.

2. Biological activity

To determine the biological activity of SMOC1, many research teams conducted cell and animal experiments. They found that SMOC1 has a significant killing effect on a variety of tumor cells and immune cells, thus proving its good biological activity and pharmacological properties.

3.Pharmacological properties

In order to determine the pharmacological properties of SMOC1, many research teams have conducted pharmacological experiments. They found that SMOC1 has good oral bioavailability and good biodistribution, resulting in good pharmacokinetic properties. In addition, they also found that SMOC1 has tumor and immunomodulatory effects, thus having broad pharmacological application prospects.

5. Conclusion

SMOC1 is a drug target with good biological activity and pharmacological properties. Its unique chemical structure and bioactive groups make it a very promising drug target. Currently, many research teams are working on

Protein Name: SPARC Related Modular Calcium Binding 1

Functions: Plays essential roles in both eye and limb development. Probable regulator of osteoblast differentiation

The "SMOC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SMOC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets